We are cost-competitive and aligned with global ESG framework demands
The biologics sector is very dependent on single-use products and containment solutions. For example, the COVID pandemic exposed…
Author
Balancing protection and compliance
2026 must be the year India’s pharma policy and industry align, as policy directives can only be successful if all sections of the…
Pharmacists can be true changemakers in population health
Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Kundnani Pharmacy Polytechnic,Ulhasnagar; Former…
From compliance to commitment: India Pharma Inc’s safety reckoning
A spate of fatal incidents at pharma plants has exposed critical gaps in workplace safety. With growing ESG scrutiny and global…
A biosimilar boost amid trade barriers
Even as India’s biggest pharma companies pursue biosimilars, product recalls related to manufacturing defects threaten to queer…
Direct-to-Retail will increasingly complement traditional pharma distribution
Aqualab has crossed Rs 100 crore in just three years, what have been the key drivers behind this growth, and how does the brand…
We can help our customers reach markets faster
Excerpts from the interview:
What’s the vision and strategy behind Merck's Formulation & Technology Center in Navi Mumbai,…
Will India pass the cough syrup trust test this time?
While India’s CDMOs are well positioned to capitalise on the booming GLP-1 market, the recurring episodes of contaminated cough…
Turning the tariff tight spot into a sweet spot
US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…
Tariff turbulence sparks a reset
India’s pharma sector is rewriting its global playbook pivoting to other markets like the EU, Africa and other geographies with…